http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022229402-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51307ca49136c8b5479c2e84df2e1f14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2022-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_986998cf2a183f22087dcf91cf67b3ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_623cf01eabe4a38b575ae6ea0e059106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40356bfe72d18dab192ef9588a3c6c93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebee2c6aa731a743b21e7d47ffd24ebf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc5cbab760a170cac2707e62ba82ceed
publicationDate 2022-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022229402-A1
titleOfInvention New formulation
abstract The present invention generally relates to an injectable formulation for sustained release of etonogestrel, a pharmaceutical dosage and an application device comprising such formulation, methods for preparing thereof, and use thereof for contraception.
priorityDate 2021-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018085248-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6350812-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014001904-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019016233-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012172454-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14049689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40973
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419573717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426208976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451349547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4523333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448069540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417109324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID612

Total number of triples: 48.